LOS ANGELES, May 23, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming July 12, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Inari Medical, Inc. ("Inari" or the "Company") (NASDAQ:NARI) common stock between February 24, 2022 through February 28, 2024, inclusive (the "Class Period").
If you suffered a loss on your Inari investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/Inari-Medical-Inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.
On February 29, 2024, Inari announced that it had received a civil investigative demand from the U.S. Department of Justice "in connection ...
NARI)>Full story available on Benzinga.com